FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

3692111000001102: Rythmodan Retard 250mg tablets (Neon Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1665571000001116 Rythmodan Retard 250mg tablets (Cheplapharm Arzneimittel GmbH) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
1665581000001119 Rythmodan Retard 250mg tablets (Cheplapharm Arzneimittel GmbH) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
1692621000001114 Rythmodan Retard 250mg tablets (Neon Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1692641000001116 Rythmodan Retard 250mg tablets (Neon Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
17573301000001118 Rythmodan Retard 250mg tablets (Borg Medicare Ltd) (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17573401000001114 Rythmodan Retard 250mg tablets (Borg Medicare Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38263001000001110 Rythmodan Retard 250mg tablets (sanofi-aventis) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
65924301000001115 Rythmodan Retard 250mg tablets (Sanofi) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rythmodan Retard 250mg tablets (Neon Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Neon Healthcare Ltd) Is a Disopyramide 250mg m/r tablet false Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Neon Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Neon Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Neon Healthcare Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Neon Healthcare Ltd) Has active ingredient Disopyramide phosphate false Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Neon Healthcare Ltd) Has active ingredient Disopyramide true Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Neon Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Neon Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Neon Healthcare Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Neon Healthcare Ltd) Is a Rythmodan Retard true Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Neon Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Disopyramide true Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Neon Healthcare Ltd) Has specific active ingredient Disopyramide phosphate true Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Neon Healthcare Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Neon Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Neon Healthcare Ltd) Has basis of strength substance Disopyramide true Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Neon Healthcare Ltd) Is a Disopyramide 250mg modified-release tablets false Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Neon Healthcare Ltd) Is a Disopyramide 250mg modified-release tablets true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Rythmodan Retard 250mg tablets (Neon Healthcare Ltd) 56 tablet Is pack of False Rythmodan Retard 250mg tablets (Neon Healthcare Ltd) Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Neon Healthcare Ltd) 56 tablet Has AMP True Rythmodan Retard 250mg tablets (Neon Healthcare Ltd) Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Neon Healthcare Ltd) 60 tablet 6 x 10 tablets Has AMP True Rythmodan Retard 250mg tablets (Neon Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start